[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.237.138.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1961

2,5 Dihydroxyphenylpyruvic Acid in Human Urine: Preliminary Identification

Author Affiliations

DETROIT; COLUMBUS, OHIO; DETROIT

From Wayne State University, Departments of Chemistry and Medicine, and The Ohio State University, Department of Medicine.

Fellow of the Michigan Heart Association (Mr. Yee); Senior Investigator of the Arthritis and Rheumatism Foundation (Dr. Denko).

Arch Dermatol. 1961;84(2):293-301. doi:10.1001/archderm.1961.01580140119015
Abstract

The immediate precursor of homogentisic acid has been the subject of speculation since Neubauer first postulated the metabolic pathways from phenylalanine and tyrosine to the citric acid cycle.1-10 In fact not all features of this theoretical flowsheet have as yet been substantiated by experimental evidence. The occurrence of 2,5 dihydroxyphenylpyruvic acid (2,5 DHPPA) in human urine has remained largely hypothetical. In 1958, Nishimura and coworkers11-12 demonstrated for the first time the presence of 2,5 DHPPA in the urine of patients with connective tissue diseases. However, the method used by them for detecting the 2,5 DHPPA was qualitative and subject to question with respect to the amount and identity of the material found. In 1959 Tye et al.,13 using ultraviolet spectrophotometry and paper chromatography, reported that 2,5 DHPPA was not detected by their methods. This paper is concerned with presenting evidence which supports the view that 2,5 DHPPA

×